Condensed Consolidated Statements of Stockholders' and Member's Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands	LLC Interests [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	LLC Interests [Member]	Common Stock [Member] Class A Common Stock [Member]	Common Stock [Member] Class B Common Stock [Member]	Additional Paid-in Capital [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Accumulated Deficit [Member]	AOCI Attributable to Parent [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Retroactive application of recapitalization (in shares)		195,800
Beginning balance at Dec. 31, 2020	$ 136,348	$ 136,348			$ 929	$ 929	$ (47,790)	$ (47,790)		$ 89,487	$ 89,487
Beginning balance (in shares) at Dec. 31, 2020	195,800
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation						480					480
Net income (loss)								(16,610)			(16,610)
Ending balance at Mar. 31, 2021		$ 136,348				1,409		(64,400)			73,357
Ending balance (in shares) at Mar. 31, 2021		195,800
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation						531					531
Net income (loss)								(18,422)			(18,422)
Ending balance at Jun. 30, 2021		$ 136,348				1,940		(82,822)			55,466
Ending balance (in shares) at Jun. 30, 2021		195,800
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equitization of note payable, related party		$ 59,590									59,590
CRIS Business Combination, net of expenses		$ (195,938)	$ 7	$ 20		234,175					38,264
CRIS Business Combination, net of expenses (in shares)		(195,800)	67,299	195,800
Share-based compensation						3,750					3,750
Vesting of earnout shares			$ 0			10,853					10,853
Vesting of earnout shares (in shares)			719
Redeemable noncontrolling interest adjustment to fair value						(250,718)		(890,319)			(1,141,037)
Net income (loss)								6,130			6,130
Ending balance at Sep. 30, 2021			$ 7	$ 20				(967,011)			(966,984)
Ending balance (in shares) at Sep. 30, 2021			68,018	195,800
Beginning balance at Dec. 31, 2021			$ 7	$ 20				(1,358,358)			(1,358,331)
Beginning balance (in shares) at Dec. 31, 2021			68,021	195,800
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation						2,999					2,999
Warrants exercised and release of warrant liability			$ 0			2					2
Issuance of stock under share-based compensation plans, including income tax effect			$ 0			0					0
Issuance of stock under share-based compensation plans, including income tax effect (in shares)			248
Redeemable noncontrolling interest adjustment to fair value						(3,001)		(609,095)			(612,096)
Net income (loss)								(14,399)			(14,399)
Ending balance at Mar. 31, 2022			$ 7	$ 20				(1,981,852)			(1,981,825)
Ending balance (in shares) at Mar. 31, 2022			68,269	195,800
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation						6,582					6,582
Warrants exercised and release of warrant liability			$ 0			1					1
Issuance of stock under share-based compensation plans, including income tax effect			$ 0			0					0
Issuance of stock under share-based compensation plans, including income tax effect (in shares)			309
Net change in unrealized gain on available-for-sale securities									$ (47)		(47)
Redeemable noncontrolling interest adjustment to fair value								1,354,074			1,354,074
Net income (loss)								4,479			4,479
Ending balance at Jun. 30, 2022			$ 7	$ 20		6,583		(623,299)	(47)		(616,736)
Ending balance (in shares) at Jun. 30, 2022			68,578	195,800
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation						6,450					6,450
Issuance of stock under share-based compensation plans, including income tax effect			$ 0			0					0
Issuance of stock under share-based compensation plans, including income tax effect (in shares)			88
Net change in unrealized gain on available-for-sale securities									$ 47		47
Redeemable noncontrolling interest adjustment to fair value						$ (13,033)		(396,114)			(409,147)
Net income (loss)								(13,218)			(13,218)
Ending balance at Sep. 30, 2022			$ 7	$ 20				$ (1,032,631)			$ (1,032,604)
Ending balance (in shares) at Sep. 30, 2022			68,666	195,800